Dr. Jeff Michael Bronstein, MD

Dr. Bronstein practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Bronstein's NPI, 1114940731, was assigned on July 25, 2006. Dr. Bronstein graduated from David Geffen School of Medicine at UCLA in 1988. Dr. Bronstein's California license number on file is G67890.

Dr. Bronstein's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Bronstein's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Bronstein is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Neurology. Dmand AI also links Dr. Bronstein to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bronstein practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Bronstein's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Bronstein is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Bronstein has a license on file in California.

Dmand AI lists essential tremor, head injury, non-alzheimer's dementia (chronic), parkinson's disease, restless legs syndrome and seizures among the conditions Dr. Bronstein treats.

CMS data shows 447 Medicare services from Dr. Bronstein across 5 procedure codes in 2024, for 195 Medicare patients. Medicare paid $54,131 for them.

CMS counts 195 Medicare patients who saw Dr. Bronstein in 2024. The largest group is 75 to 84, with 82 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.86, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bronstein's median patient age at 70, with 37% women.

In 2024, Dr. Bronstein wrote 2,478 Medicare Part D claims for 153 patients. 73% of them were for generic drugs. CMS names the drug for 2,255 of them, across 41 drugs with 11 or more claims each, at $2,583,026 in total drug cost. In 2023, CMS named 2,361 claims across 42 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Bronstein for performance year 2024, reported as part of a group. Dr. Bronstein accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bronstein as offering telehealth.

Dmand AI links 8 papers to Dr. Bronstein, published from 2010 to 2025. Dr. Bronstein's most frequent co-authors are William John Marks, MD, Ron L. Alterman, MD and Frederick K. Askari, MD, PhD.

Dmand AI links Dr. Bronstein to 3 clinical trials, 2 of them phase 3 studies. Conditions studied include Helicobacter Infections, Hepatolenticular Degeneration and Parkinson Disease.

CMS Open Payments shows 27 general payments to Dr. Bronstein from 7 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 88% of the total. Alexion Pharmaceuticals, Inc. paid the most, $11,825.

Dmand AI lists 1 award for Dr. Bronstein.

Dr. Bronstein graduated from David Geffen School of Medicine at UCLA in 1988.

Dr. Bronstein is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.